(Press-News.org) Preclinical, laboratory studies suggest a novel immunotherapy could potentially work like a vaccine against metastatic cancers, according to scientists at Virginia Commonwealth University Massey Cancer Center. Results from a recent study show the therapy could treat metastatic cancers and be used in combination with current cancer therapies while helping to prevent the development of new metastatic tumors and train specialized immune system cells to guard against cancer relapse.
Recently published in the journal Cancer Research, the study detailed the effects of a molecule engineered by lead author Xiang-Yang Wang, Ph.D., on animal and cell models of melanoma, prostate and colon tumors. The molecule called Flagrp-170 consists of two distinct proteins, glucose-regulated protein 170 (Grp170), known as a "molecular chaperone," and a "danger signal" derived from flagellin, a protein commonly found in bacteria. The researchers used modified viruses, or adenoviruses, that can no longer replicate to transport Flagrp-170 directly to the tumor site to achieve localized vaccination. The novel therapy caused a profound immune response that significantly prolonged survival in animal models.
"Successfully promoting antitumor immunity will help eradicate tumor cells, control cancer progression and help prevent tumor relapse," says Wang, Harrison Scholar, member of the Cancer Molecular Genetics research program at VCU Massey Cancer Center and associate professor of Human and Molecular Genetics at VCU School of Medicine. "This immunotherapy has the potential to be used alone or in combination with conventional cancer treatments to develop and establish immune protection against cancer and its metastases."
Grp170 is currently being explored for its potential as a "cancer vaccine" because it has been shown to help the immune system recognize cancer antigens. Antigens are molecules from foreign objects such as bacteria, viruses or cancer that, when detected, provoke an immune response aimed at attacking them. However, because cancer cells can alter the microenvironment surrounding a tumor, they are able to suppress immune responses and continue replicating without being attacked by the body's natural defenses.
The chimeric chaperone Flagrp-170, created by strategically fusing a fragment of flagellin to Grp170, not only enhances antigen presentation, it also stimulates additional immune signals essential for functional activation of specialized immune cells, including dendritic cells, CD8+ T lymphocytes and natural killer (NK) cells. Dendritic cells act as messengers between the innate and adaptive immune systems. Once activated in response to a stimulus such as Flagrp-170, dendritic cells migrate to lymph nodes where they interact with other immune cells such as T lymphocytes to shape the body's immune response. CD8+ T lymphocytes and NK cells are known to respond to tumor formation and kill cancer cells by triggering apoptosis, a form of cell suicide.
"Overcoming cancer's ability to suppress the body's natural immune responses and restore or develop immunity for tumor eradication is the goal of cancer immunotherapy," says Wang. "More experiments are needed, but we are hoping Flagrp-170 may one day be used in formulating more effective therapeutic cancer vaccines."
Moving forward, Wang and his team are working to better understand the molecular mechanisms responsible for Flagrp-170's therapeutic effects. Additional studies are underway to more efficiently target and deliver Flagrp-170 to tumor sites in order to provoke a more robust and durable immune response.
INFORMATION:
Wang collaborated on this research with Paul Fisher, M.Ph., Ph.D., Thelma Newmeyer Corman Endowed Chair in Cancer Research and program co-leader of Cancer Molecular Genetics at VCU Massey Cancer Center, chairman of VCU's Department of Human and Molecular Genetics and director of the VCU Institute of Molecular Medicine; Xiaofei Yu; Chunquing Guo, Ph.D.; Huanfa Yi; and Jie Qian, Ph.D., all from VCU's Department of Human and Molecular Genetics and the VCU Institute of Molecular Medicine; and John R. Subjeck from the Department of Cellular Stress Biology at Roswell Park Cancer Institute.
This research was supported by NIH grants CA129111 and CA154708; the American Cancer Society, the Department of Defense and, in part, by funding from VCU Massey Cancer Center's NIH-NCI Cancer Center Support Grant P30 CA016059.
The full manuscript of this study is available online at: http://cancerres.aacrjournals.org/content/early/2013/01/18/0008-5472.CAN-12-1740.long.
News directors: Broadcast access to VCU Massey Cancer Center experts is available through VideoLink ReadyCam. ReadyCam transmits video and audio via fiber optics through a system that is routed to your newsroom. To schedule a live or taped interview, contact John Wallace.
About VCU Massey Cancer Center:
VCU Massey Cancer Center is one of only 67 National Cancer Institute-designated institutions in the country that leads and shapes America's cancer research efforts. Working with all kinds of cancers, the Center conducts basic, translational and clinical cancer research, provides state-of-the-art treatments and clinical trials, and promotes cancer prevention and education. Since 1974, Massey has served as an internationally recognized center of excellence. It has one of the largest offerings of clinical trials in Virginia and serves patients in Richmond and in four satellite locations. Its 1,000 researchers, clinicians and staff members are dedicated to improving the quality of human life by developing and delivering effective means to prevent, control and ultimately to cure cancer. Visit Massey online at www.massey.vcu.edu or call 877-4-MASSEY for more information.
About VCU and the VCU Medical Center:
Virginia Commonwealth University is a major, urban public research university with national and international rankings in sponsored research. Located in downtown Richmond, VCU enrolls more than 31,000 students in 222 degree and certificate programs in the arts, sciences and humanities. Sixty-six of the programs are unique in Virginia, many of them crossing the disciplines of VCU's 13 schools and one college. MCV Hospitals and the health sciences schools of Virginia Commonwealth University compose the VCU Medical Center, one of the nation's leading academic medical centers. For more, see www.vcu.edu.
New cancer 'vaccine' shows future promise in treating and preventing metastatic cancers
2013-02-27
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Youth's addiction recovery predicted with AA-related helping tool
2013-02-27
A Case Western Reserve University professor has found that young people addicted to alcohol and drugs can increase their chances of recovery by helping others.
In 2010, Maria Pagano, PhD, found that adults who became involved in Alcoholics Anonymous-related service-type work were more likely to stay sober 10 years following treatment and have increased interest in others, a positive health outcome.
Now, new research by Pagano finds that youths in AA respond the same way. In a study of nearly 200 juvenile offenders, she found that youth who became active in AA-related ...
Defining the new normal in aging
2013-02-27
Diana McIntyre approaches her 80th birthday later this year with the same energy and zest for life of friends decades her junior. Aside from back surgery years ago, she's never been sick and, through a busy volunteer schedule, never seems to slow down.
McIntyre's good health feels normal—at least to her—although she recognizes not all seniors are so fortunate. But when it comes to terms like "normal," "healthy" or "successful" aging, she shakes her head.
"I don't know what would be considered normal aging," said McIntyre, past president of the Seniors Association of ...
Trust makes you delusional and that's not all bad
2013-02-27
EVANSTON, Ill. --- Trust fools you into remembering that your partner was more considerate and less hurtful than he or she actually was.
New research from Northwestern University and Redeemer University College (Ontario, Canada) is the first to systematically examine the role of trust in biasing memories of transgressions in romantic partnerships.
People who are highly trusting tended to remember transgressions in a way that benefits the relationship, remembering partner transgressions as less severe than they originally reported them to be. People low on trust demonstrated ...
New insight into how people choose insurance plans
2013-02-27
Economists often talk about "moral hazard," the idea that people's behavior changes in the presence of insurance. In finance, for instance, investors may take more risks if they know they will be bailed out, the subject of ongoing political controversy.
When it comes to health insurance, the existence of moral hazard is a more matter-of-fact issue: When people get health insurance, they use more medical care, as shown by research including a recent randomized study on the impact of Medicaid, which MIT economist Amy Finkelstein helped lead.
Such evidence helps explain ...
Good bacteria may expunge vancomycin-resistant bacteria from your gut
2013-02-27
Too much antibiotic can decimate the normal intestinal microbiota, which may never recover its former diversity. That, in turn, renders the GI tract vulnerable to being colonized by pathogens. Now researchers from Memorial Sloan-Kettering Cancer Center, New York, NY, and Centro Superior de Investigación en Salud Pública, Valencia, Spain, show that reintroducing normal microbial diversity largely eliminated vancomycin-resistant enterococci (VRE) from the intestinal tracts of mice. The investigators showed further that the findings may apply to humans. The research is published ...
Wayne State study shows airborne dust in urban areas impacts lead levels in children
2013-02-27
DETROIT – A team of researchers led by Shawn P. McElmurry, Ph.D., P.E., assistant professor of civil and environmental engineering in Wayne State University's College of Engineering, has confirmed that seasonal fluctuations in blood lead levels found in children in urban areas throughout the United States and elsewhere in the northern hemisphere are the result of resuspended dust contaminated with lead.
The study, published in the journal Environmental Science and Technology was based on nine years of data on more than 367,000 children in Detroit. The team of scientists ...
Surgery and radiation improve survival for metastatic gastric cancer patients, Moffitt study shows
2013-02-27
Researchers at Moffitt Cancer Center studied patients with metastatic gastric cancer and found that those who have both surgery and radiation have better survival than those who receive one or no form of treatment.
The study appeared in an online issue of Cancer.
"There were an estimated 21,000 new cases of gastric cancer in the United States in 2010 and 11,000 deaths from the disease," said Ravi Shridhar, M.D., Ph.D., of the Radiation Oncology Department at Moffitt. "Most gastric cancers are diagnosed at advanced stages, when surgery may not be an option."
Until ...
Study connects early childhood with pain, depression in adulthood
2013-02-27
It's common knowledge that a child who misses a meal can't concentrate in school. But what happens years down the road? Does that missed meal have any bearing on health in adulthood?
A new University of Nebraska-Lincoln study shows that missed meals in childhood can be linked to experiencing pain and depression in adulthood. Depression and chronic pain are experienced by 44 percent of working-aged adults and the study shows a correlation between childhood conditions and pain and depression in adulthood.
The study by UNL sociologist Bridget Goosby examines how childhood ...
Research update: Chemists find help from nature in fighting cancer
2013-02-27
CAMBRIDGE, MA -- Inspired by a chemical that fungi secrete to defend their territory, MIT chemists have synthesized and tested several dozen compounds that may hold promise as potential cancer drugs.
A few years ago, MIT researchers led by associate professor of chemistry Mohammad Movassaghi became the first to chemically synthesize 11,11'-dideoxyverticillin, a highly complex fungal compound that has shown anti-cancer activity in previous studies. This and related compounds naturally occur in such small amounts that it has been difficult to do a comprehensive study of ...
Unlocking fuel cell conductivity
2013-02-27
Yttria stabilized zirconia, also known as YSZ, is a material of great interest because of its relatively high oxygen-ion based conductivity. In particular, it finds applications in electrochemical devices, such as solid oxide fuel cells and oxygen sensors. In a study published in EPJ B, Kia Ngai, from the University of Pisa in Italy, and colleagues from the Complutense University in Madrid, Spain, devised a model of the oxygen-ion dynamics that contribute to the conductivity of YSZ.
The problem is that fuel cells currently operate above 700 ºC, which strongly limits their ...